| The Pharmaceutical Journal |
|
News summary |
| Related websites |
EHC consumption up by 20 per centUse of emergency hormonal contraception (EHC) has risen by nearly a fifth in England since the introduction of Levonelle as a pharmacy medicine in January 2002, despite a reduction in EHC prescribing. Department of Health figures show that 783,800 courses of EHC were prescribed in 2000–01 compared with 620,000 in 2001–02. According to Schering, about a third of EHC sales have been through pharmacies. Therefore roughly 310,000 courses of Levonelle were sold as a pharmacy medicine or supplied under patient group directions during 2001–02 — an estimated 930,000 courses in total and an 18.7 per cent increase on last year. |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal